ArticleInternational journal of cancer2026

Neoadjuvant endocrine therapy often leads to breast and axilla-conserving surgery in stages II and III hormone receptor-positive breast cancer patients: A registry study.

Layla Andour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.